id: clinic_acceptance_policies_pregnant_patients_to_oud_medication_treatment_access
name: Clinic Policies Refusing Pregnant Patients â†’ Access to OUD Medication Treatment
from_node:
  node_id: clinic_acceptance_policies_pregnant_patients
  node_name: Clinic Policies Refusing Pregnant Patients
to_node:
  node_id: oud_medication_treatment_access
  node_name: Access to OUD Medication Treatment
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Healthcare facilities implement policies excluding pregnant patients from
  OUD treatment services'
- 'Step 2: Nearly half (48%) of buprenorphine clinics refuse to treat pregnant patients
  as baseline practice'
- 'Step 3: Pregnant patients with OUD are systematically excluded from evidence-based
  medication treatment options'
- 'Step 4: Reduced treatment access increases risks of continued untreated opioid
  use, overdose, and adverse maternal-fetal outcomes'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Ashley C. Lensch et al. 2021. "Pregnant Patients Using Opioids:
    Treatment Access Barriers in the Age of COVID-19." *Journal of addiction medicine*.
    https://doi.org/10.1097/ADM.0000000000000826'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.702562'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
